Register for our free email digests:
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Spine firm NuVasive has named Rajesh Asarpota as the company's new executive vice president and chief financial officer. He steps in after the previous CFO left following NuVasive's disappointing Q2 2017 results.
Atlantic Therapeutics has appointed former Zeltiq Aesthetics CEO Gordie Nye as its new chairman to help drive adoption of its CE-marked Innovo device for treating clinical conditions associated with pelvic floor weakness.
GE Healthcare has appointed Catherine Estrampes as CEO of its European operations, replacing Jean-Michel Malbrancq who is leaving to pursue opportunities outside of GE after 35 years with the company.
French ortho medical imaging specialist EOS imaging has made two new senior leadership appointments. Mike Lobinsky joins in a newly created role as US President while Pierre Schwich has been hired as the company's new CFO.
Axogen has hired Boston Scientific alumnus Jon Gingrich to the newly created role of chief commercial officer (CCO). Gingrich will oversee development and execution of the company's sales and marketing development as it expands its portfolio of nerve regeneration products.
On this week's Medtech Insight podcast: FDARA user-fee bill progresses in the US Congress; a deep-dive look into the US Open Payments database yields interesting news and trends; in an unusual step, US FDA publicly shares 483 inspection observation form after troublesome Magellan Diagnostics audit; standards organization GS1 and the Healthcare Industry Distributors Association try to solve billing headaches; top management shaken up at Zimmer Biomet.
David Dvorak has stepped down as president and CEO, and from the company's board, and CFO Daniel P. Florin will take over as interim CEO, the orthopedics giant announced July 11. The company also announced preliminary second-quarter sales and earnings that, while within the previously projected range, included disappointments for several product lines.
Howard Sklamberg, the former US FDA deputy commissioner for global regulatory operations and policy who left the agency in April, will now join the health-care practice at the law firm Akin Gump.
FDA promotes Denise Hinton to acting chief scientist after Luciana Borio is detailed to the National Security Council for biodefense work
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.